[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.166.22. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
July 2001

Fifteen Years of WorkThe COMS Outcomes for Medium-Sized Choroidal Melanoma

Arch Ophthalmol. 2001;119(7):1067-1068. doi:10.1001/archopht.119.7.1067

CHOROIDAL MELANOMA is the most common primary ocular malignancy, with some 1500 new cases reported yearly in the United States. These tumors are both sight- and life-threatening, with approximately a 10% to 30% five-year mortality rate owing to systemic metastasis, depending on tumor size. Despite the major morbidity and mortality from these tumors, the condition occurs infrequently enough in any single ophthalmic practice of considerable size that clinical expertise in the condition had been difficult to accumulate in years past. Even the accurate diagnosis of choroidal melanoma had been sufficiently difficult to make, and an unfortunate fraction of eyes enucleated were found to have some other condition.

First Page Preview View Large
First page PDF preview
First page PDF preview
×